Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M132Revenue (TTM) $M23.4Net Margin (%)-105.6Altman Z-Score-6.4
Enterprise Value $M135EPS (TTM) $-0.9Operating Margin %-81.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.1Pre-tax Margin (%)-105.0Higher ROA y-yN
Price/Book4.810-y EBITDA Growth Rate %--Quick Ratio3.0Cash flow > EarningsY
Price/Sales5.15-y EBITDA Growth Rate %--Current Ratio3.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-41.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-91.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M31.9ROIC % (ttm)-80.1Gross Margin Increase y-yY

Gurus Latest Trades with CRME

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CRME is held by these investors:



CRME: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Archibald, JenniferSenior Officer 2014-09-08Buy75$7.29-43.35view
Archibald, JenniferSenior Officer 2014-09-05Buy4,100$7.25-43.03view
Archibald, JenniferSenior Officer 2014-09-05Buy100$7.22-42.8view
Archibald, JenniferSenior Officer 2014-09-05Buy3,259$6.7-38.36view
Hunter, William L.Director, Senior Officer 2014-09-05Buy31,000$6.74-38.72view
Hunter, William L.Director, Senior Officer 2014-09-04Buy19,000$6.65-37.89view
RIEDER, ROBERTDirector, Director or Senior Officer of Insider or 2014-06-27Sell2,000$8.65-52.25view
RIEDER, ROBERTDirector, Director or Senior Officer of Insider or 2014-06-26Sell1,500$8.65-52.25view
RIEDER, ROBERTDirector, Director or Senior Officer of Insider or 2014-06-25Sell300$8.63-52.14view
RIEDER, ROBERTDirector, Director or Senior Officer of Insider or 2014-06-25Sell2,000$8.64-52.2view

Press Releases about CRME :

Quarterly/Annual Reports about CRME:

    News about CRME:

    Articles On GuruFocus.com
    Cardiome Reports Changes To Senior Management Team May 16 2017 
    Cardiome Reports First Quarter 2017 Financial Results May 15 2017 
    Cardiome Announces Amendment to Term Loan Agreement with CRG-Managed Funds May 15 2017 
    Cardiome To Hold First Quarter 2017 Financial Results Conference Call On May 15 May 08 2017 
    Cardiome to Present at the Bloom Burton & Co. 6th Annual Healthcare Investor Conference Apr 27 2017 
    Cardiome's Partner SteadyMed Announces Successful Completion of Trevyent® Clinical Validation Study Apr 06 2017 
    Cardiome's Partner SteadyMed Receives Favourable Ruling in its USPTO Inter Partes Review Apr 03 2017 
    Novelion Therapeutics Appoints Mark Corrigan, M.D. to Board of Directors Mar 31 2017 
    A Closer Look Into Veritas Pharma Apr 21 2016 
    Cardiome Closes US$23 Million Bought Deal Financing Aug 13 2015 

    More From Other Websites
    Cardiome Pharma Corp. :CRME-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017 May 19 2017
    Cardiome Pharma (CRME) Looks Good: Stock Moves 6.1% Higher May 18 2017
    Cardiome (CRME) Q1 Loss Wider Than Expected, Sales Miss May 17 2017
    Cardiome Reports Changes To Senior Management Team May 16 2017
    Cardiome reports 1Q loss May 15 2017
    Cardiome Reports First Quarter 2017 Financial Results May 15 2017
    Investor Network: Cardiome Pharma Corp. to Host Earnings Call May 15 2017
    Cardiome Announces Amendment to Term Loan Agreement with CRG-Managed Funds May 15 2017
    Cardiome To Hold First Quarter 2017 Financial Results Conference Call On May 15 May 08 2017
    Cardiome to Present at the Bloom Burton & Co. 6th Annual Healthcare Investor Conference Apr 27 2017
    Cardiome Pharma (CRME) Jumps: Stock Adds 6.6% in Session Apr 10 2017
    Cardiome's Partner SteadyMed Announces Successful Completion of Trevyent® Clinical Validation Study Apr 06 2017
    Cardiome's Partner SteadyMed Receives Favourable Ruling in its USPTO Inter Partes Review Apr 03 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)